Vertex Announces Positive Results From Phase 2 Study of VX-548 for the Treatment of Painful Diabetic Peripheral Neuropathy | Vertex Pharmaceuticals Newsroom – news.vrtx.com

by

  1. Vertex Announces Positive Results From Phase 2 Study of VX-548 for the Treatment of Painful Diabetic Peripheral Neuropathy | Vertex Pharmaceuticals Newsroom news.vrtx.com
  2. Vertex shares pop after nonopioid painkiller posts positive midstage trial results CNBC
  3. Vertex Pharmaceuticals Jumps on Pain Medication Success: How to Play It RealMoney
  4. Vertex Rallies, Flashes Bullish Signal On Phase 2 Results For Opioid Alternative Investor’s Business Daily
  5. Vertex passes neuropathic pain test, teeing up pivotal trials in pursuit of blockbuster opportunity FierceBiotech

Read original article here

Leave a Comment